NCT00223964

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Randomized Double-Blind Parallel Group MultiCenter Study of the Efficacy of Two Doses of Ferrlecit® in Treatment of Iron Deficiency in Pediatric Hemodialysis Patients Receiving Epoetin.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 59 (actual)
• Sponsor: Watson Pharmaceuticals · Industry
• Sex: All
• Age: 2 Years – 16 Years
• Healthy volunteers: Not accepted

Summary

This was a multi-center study in iron-deficient pediatric hemodialysis patients, whose legal guardian had provided signed informed consent and satisfied the inclusion and exclusion criteria.

Conditions

• Anemia

Interventions

Type	Name	Description
DRUG	Ferrlecit (sodium ferric gluconate complex in sucrose injection)

Timeline

• Start date: 2003-06-01
• Primary completion: 2003-10-01
• First posted: 2005-09-22
• Last updated: 2012-08-14

Locations

24 sites across 5 countries: United States, Mexico, Poland, Russia, Serbia